Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328)

Por Bosch, Ronald J, Pollard, Richard B, Landay, Alan, Aga, Evgenia, Fox, Lawrence, Mitsuyasu, Ronald
Publicado em 2010

A Randomized Trial of Interleukin-2 During Withdrawal of Antiretroviral Treatment

Por Bosch, Ronald J., Pollard, Richard B., Landay, Alan, Aga, Evgenia, Fox, Lawrence, Mitsuyasu, Ronald
Publicado em 2011

Augmented HIV-specific Interferon-gamma Responses, but Impaired Lymphoproliferation During Interruption of Antiretroviral Treatment Initiated in Primary HIV Infection

Por Connick, Elizabeth, Bosch, Ronald J., Aga, Evgenia, Schlichtemeier, Rick, Demeter, Lisa M., Volberding, Paul
Publicado em 2011

Antiretroviral Drug Resistance in HIV-1–Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy

Por Taiwo, Babafemi, Gallien, Sebastien, Aga, Evgenia, Ribaudo, Heather, Haubrich, Richard, Kuritzkes, Daniel R., Eron, Joseph J.
Publicado em 2011

Hyperlipidemia in HIV-Infected Patients on Lopinavir/Ritonavir Monotherapy in Resource-Limited Settings

Por Matoga, Mitch M., Hosseinipour, Mina C., Aga, Evgenia, Ribaudo, Heather J., Kumarasamy, Nagalingeswaran, Bartlett, John, Hughes, Michael D.
Publicado no Antivir Ther (2016)

Drug Susceptibility and Resistance Mutations After First-Line Failure in Resource Limited Settings

Por Wallis, Carole L., Aga, Evgenia, Ribaudo, Heather, Saravanan, Shanmugam, Norton, Michael, Stevens, Wendy, Kumarasamy, Nagalingeswaran, Bartlett, John, Katzenstein, David
Publicado em 2014

Antiretroviral Therapy in Acute and Recent HIV Infection: A Prospective Multicenter Stratified Trial of Intentionally Interrupted Treatment

Por Volberding, Paul, Demeter, Lisa, Bosch, Ronald J., Aga, Evgenia, Pettinelli, Carla, Hirsch, Martin, Vogler, Mary, Martinez, Ana, Little, Susan, Connick, Elizabeth
Publicado em 2009

Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials

Por Treasure, Graham C., Aga, Evgenia, Bosch, Ronald J., Mellors, John W., Kuritzkes, Daniel R., Para, Michael, Gandhi, Rajesh T., Li, Jonathan Z.
Publicado no J Acquir Immune Defic Syndr (2016)

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1–Infected Adults Receiving Long-term Antiretroviral Therapy

Por Riddler, Sharon A., Aga, Evgenia, Bosch, Ronald J., Bastow, Barbara, Bedison, Margaret, Vagratian, David, Vaida, Florin, Eron, Joseph J., Gandhi, Rajesh T., Mellors, John W.
Publicado no J Infect Dis (2016)

Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA

Por Hong, Feiyu, Aga, Evgenia, Cillo, Anthony R., Yates, Aarika L., Besson, Guillaume, Fyne, Elizabeth, Koontz, Dianna L., Jennings, Cheryl, Zheng, Lu, Mellors, John W.
Publicado no J Clin Microbiol (2016)

The Size of the Expressed HIV Reservoir Predicts Timing of Viral Rebound after Treatment Interruption

Por Li, Jonathan Z., Etemad, Behzad, Ahmed, Hayat, Aga, Evgenia, Bosch, Ronald J., Mellors, John W., Kuritzkes, Daniel R., Lederman, Michael M., Para, Michael, Gandhi, Rajesh T.
Publicado no AIDS (2016)

Residual Plasma Viremia and Infectious HIV-1 Recovery from Resting Memory CD4 Cells in Patients on Antiretroviral Therapy: Results from ACTG A5173

Por Gandhi, Rajesh T., Bosch, Ronald J., Aga, Evgenia, Bedison, Margaret A., Bastow, Barbara, Schmitz, John L., Siliciano, Janet D., Siliciano, Robert F., Eron, Joseph J., Mellors, John W.
Publicado em 2013

HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy

Por Besson, Guillaume J., Lalama, Christina M., Bosch, Ronald J., Gandhi, Rajesh T., Bedison, Margaret A., Aga, Evgenia, Riddler, Sharon A., McMahon, Deborah K., Hong, Feiyu, Mellors, John W.
Publicado em 2014

No Evidence for Decay of the Latent Reservoir in HIV-1–Infected Patients Receiving Intensive Enfuvirtide-Containing Antiretroviral Therapy

Por Gandhi, Rajesh T., Bosch, Ronald J., Aga, Evgenia, Albrecht, Mary, Demeter, Lisa M., Dykes, Carrie, Bastow, Barbara, Para, Michael, Lai, Jun, Siliciano, Robert F., Siliciano, Janet D., Eron, Joseph J.
Publicado em 2010

Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230

Por Kumarasamy, Nagalingeswaran, Aga, Evgenia, Ribaudo, Heather J., Wallis, Carole L., Katzenstein, David A., Stevens, Wendy S., Norton, Michael R., Klingman, Karin L., Hosseinipour, Mina C., Crump, John A., Supparatpinyo, Khuanchai, Badal-Faesen, Sharlaa, Bartlett, John A.
Publicado no Clin Infect Dis (2015)

Lopinavir/ritonavir Monotherapy After Virologic Failure of First-line Antiretroviral Therapy in Resource-limited Settings

Por Bartlett, John A., Ribaudo, Heather J., Wallis, Carole L., Aga, Evgenia, Katzenstein, David K., Stevens, Wendy S., Norton, Michael R., Klingman, Karin L., Hosseinipour, Mina C., Crump, John A., Supparatpinyo, Khuanchai, Badal-Faesen, Sharlaa, Kallungal, Beatrice A., Kumarasamy, Nagalingeswaran
Publicado em 2012

IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection

Por Sereti, Irini, Dunham, Richard M., Spritzler, John, Aga, Evgenia, Proschan, Michael A., Medvik, Kathy, Battaglia, Catherine A., Landay, Alan L., Pahwa, Savita, Fischl, Margaret A., Asmuth, David M., Tenorio, Allan R., Altman, John D., Fox, Lawrence, Moir, Susan, Malaspina, Angela, Morre, Michel, Buffet, Renaud, Silvestri, Guido, Lederman, Michael M.
Publicado em 2009